Flushing, NY: A bus accident involving a charter bus driven by a man who was fired by the New York Metropolitan Transportation Authority (MTA) two years ago, has killed three people, including the driver, and injured at least 16. [Original Article]
Class Action Lawsuit Headlines
-
Potential Lawsuit: Flushing Bus Accident Causes Death and Injuries
-
Settlement: $13M Award in Asbestos Mesothelioma Lawsuit
Alameda, CA: A $12,958,461 verdict has been awarded against The Hillshire Brands Company in a products liability suit alleging asbestos contamination resulting in death from asbestos mesothelioma. [Original Article]
-
Potential Lawsuit: Medtronic Urgent Recall of MiniMed Insulin Infusion Sets
Washington, DC: Medtronic in conjunction with the US Food and Drug Administration, has issued an urgent, global recall of its defective Medtronic MiniMed Paradigm Insulin Infusion Sets following reports of a potential safety issue that can occur if insulin or other fluids come in contact with the inside of Medtronic Paradigm infusion sets. [Original Article]
-
Potential Lawsuit: Class I Recall Issued for Datascope Intra-Aortic Balloon Pumps
Washington, DC: Datascope Corp./MAQUET is recalling 5,049 defective CS100i, CS100, and CS300 Intra-Aortic Balloon Pumps made from July 1, 2003 to June 16, 2017 due to False Blood Detection Alarm and Ingress of Fluid into the Intra-Aortic Balloon Pump. [Original Article]
-
Settlement: $60M Deal Reached in Victoza Fraud Cases
Washington, DC: A $60 million deal has been agreed between Novo Nordisk Inc., and federal agencies who alleged the pharmaceutical company engaged in misleading marketing practices concerning its best selling Type 2 diabetes drug Victoza. [Original Article]
-
Potential Lawsuit: Smith & Nephew Defective Knee Replacements
Santa Cruz, CA: Allegations of knee replacement failure are being made against device manufacturer Smith & Nephew. In some cases people have filed personal injury and defective knee replacement lawsuits. [Original Article]
-
Settlement: $67M Settlement Reached in Mylan Antitrust Lawsuit
Washington, DC: Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories have been ordered to pay $67 million in fines to end the long-running antitrust lawsuit brought by Blue Cross. [Original Article]
-
Potential Lawsuit: FDA Issues Corrective Recalls over St. Jude Pacemakers Cyber Security
Santa Clara, CA: The US Food and Drug Administration (FDA) has issued a recall specifically for corrective action, to reduce the risk of patient harm due to potential exploitation of cybersecurity vulnerabilities for certain Abbott (formerly St. Jude Medical) pacemakers. [Original Article]